GAITHERSBURG, Md., May16, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, to the position of Chief Medical Officer.Dr. Tasker joined the company in April 2016 as Senior Vice Presid...Read More
GAITHERSBURG, Md., June19, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a corporate overview at the BIO International Convention, taking place...Read More
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2017) - Trading resumes in: Company: Altamira Gold Corp. TSX-V Symbol: ALTA Resumption Time (ET): 08:00 April 18,2017 IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed...Read More
VANCOUVER, April 17, 2017 /CNW/ - Trading resumes in: Company: ALTAMIRA GOLD CORP., Formerly Equitas Resources Corp. ("EQT") TSX-Venture Symbol: ALTA Resumption (ET): Tuesday April 18/17- 08:00 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security o...Read More
Altamira Gold Corp. Announces Commencement of Trenching Program at Cajueiro Project, Brazil Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), formerly Equitas Resources Corp. ("Altamira" or the "Company") is pleased to announce that it has commenced a program of...Read More
Altamira Gold Corp. announces commencement of drill program at Cajueiro Project, Brazil Vancouver, BC (FSCwire) - Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (USA: EQTRF), formerly Equitas Resources Corp. ("Altamira" or the "Company") is pleased to announce that it has commenced the planned prog...Read More